The first-ever systematic study of the genomes of patients with ALK-negative anaplastic large cell lymphoma (ALCL), a particularly aggressive form of non-Hodgkin's lymphoma, shows that many cases of the disease are driven by alterations in the JAK/STAT3 cell signaling pathway.
from The Medical News http://ift.tt/1FU3FUg
from The Medical News http://ift.tt/1FU3FUg
No comments:
Post a Comment